celiprolol has been researched along with endothelin-1 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Daniel, WG; Garlichs, CD; Mügge, A; Zhang, H | 1 |
Kobayashi, N; Matsuoka, H; Mita, S; Tsubokou, Y; Yoshida, K | 1 |
2 other study(ies) available for celiprolol and endothelin-1
Article | Year |
---|---|
Beta-blockers reduce the release and synthesis of endothelin-1 in human endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenergic beta-Antagonists; Celiprolol; Cells, Cultured; Culture Media, Conditioned; Dose-Response Relationship, Drug; Endothelin-1; Endothelins; Endothelium, Vascular; Humans; Metoprolol; Propanolamines; Propranolol; Protein Precursors; RNA, Messenger; Thrombin | 1999 |
Celiprolol inhibits mitogen-activated protein kinase and endothelin-1 and transforming growth factor-beta(1) gene in rats.
Topics: Adrenergic beta-Antagonists; Animals; Blotting, Western; Body Weight; Celiprolol; Desoxycorticosterone; Endothelin-1; Gene Expression Regulation; Heart Ventricles; Hemodynamics; Hypertension; Male; Mitogen-Activated Protein Kinases; Organ Size; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Remodeling | 2002 |